Blue Trust Inc. Has $152,000 Stock Position in Encompass Health Co. (NYSE:EHC)

Blue Trust Inc. lifted its stake in Encompass Health Co. (NYSE:EHC) by 1,019.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,578 shares of the company’s stock after buying an additional 1,437 shares during the period. Blue Trust Inc.’s holdings in Encompass Health were worth $152,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the period. UMB Bank n.a. lifted its holdings in Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC grew its stake in Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new stake in shares of Encompass Health during the third quarter worth approximately $40,000. Finally, Tompkins Financial Corp bought a new position in shares of Encompass Health in the fourth quarter valued at approximately $46,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Trading Up 1.0 %

EHC opened at $102.18 on Thursday. The firm has a 50 day simple moving average of $96.43 and a 200 day simple moving average of $95.08. Encompass Health Co. has a fifty-two week low of $71.79 and a fifty-two week high of $104.55. The company has a market cap of $10.29 billion, a price-to-earnings ratio of 24.68, a price-to-earnings-growth ratio of 1.18 and a beta of 0.90. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Analyst Upgrades and Downgrades

EHC has been the subject of a number of recent analyst reports. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp lifted their price target on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a report on Tuesday, October 29th. Barclays increased their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.